• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies.

作者信息

Warkentin Theodore E, Baskin-Miller Jacquelyn, Raybould Alison L, Sheppard Jo-Ann I, Daka Mercy, Nazy Ishac, Moll Stephan

机构信息

McMaster University, Hamilton, ON, Canada

University of North Carolina School of Medicine, Chapel Hill, NC.

出版信息

N Engl J Med. 2023 Aug 10;389(6):574-577. doi: 10.1056/NEJMc2307721.

DOI:10.1056/NEJMc2307721
PMID:37590457
Abstract
摘要

相似文献

1
Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies.腺病毒相关的血小板减少、血栓形成及VITT样抗体
N Engl J Med. 2023 Aug 10;389(6):574-577. doi: 10.1056/NEJMc2307721.
2
More on Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies. Reply.
N Engl J Med. 2023 Nov 2;389(18):1729-1731. doi: 10.1056/NEJMc2310644.
3
More on Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies.更多关于腺病毒相关血小板减少症、血栓形成和VITT样抗体的内容。
N Engl J Med. 2023 Nov 2;389(18):1729. doi: 10.1056/NEJMc2310644.
4
VITT and Second Doses of Covid-19 Vaccine.疫苗诱导的免疫性血小板减少症（VITT）与新冠病毒疾病-19疫苗第二剂
N Engl J Med. 2022 Jan 6;386(1):95. doi: 10.1056/NEJMc2118507. Epub 2021 Dec 22.
5
Validation of the newly proposed Brighton Collaboration case definition for vaccine-induced immune thrombocytopenia and thrombosis.验证新提出的用于疫苗诱导的免疫性血小板减少症和血栓形成的布莱顿协作组病例定义。
Vaccine. 2024 Nov 14;42(25):126131. doi: 10.1016/j.vaccine.2024.07.032. Epub 2024 Jul 12.
6
Hematology in the post-COVID era: spotlight on vaccine-induced immune thrombotic thrombocytopenia and a conceptual framework (the 4P's) for anti-PF4 diseases.后 COVID 时代的血液学：聚焦疫苗诱导的免疫性血栓性血小板减少症和抗 PF4 疾病的概念框架（4P's）。
Expert Rev Hematol. 2024 Jan-Mar;17(1-3):39-45. doi: 10.1080/17474086.2023.2298333. Epub 2023 Dec 27.
7
Potential mechanisms of vaccine-induced thrombosis.疫苗诱导血栓形成的潜在机制。
Eur J Intern Med. 2022 Nov;105:1-7. doi: 10.1016/j.ejim.2022.08.002. Epub 2022 Aug 8.
8
Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis.疫苗诱导的免疫性血小板减少症和血栓形成的长期结局。
J Thromb Haemost. 2023 Sep;21(9):2519-2527. doi: 10.1016/j.jtha.2023.06.027. Epub 2023 Jun 30.
9
Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.疑似接种 ChAdOx1 nCoV-19 后出现 VITT 患者的临床评估路径。
Blood Adv. 2022 Jun 14;6(11):3315-3320. doi: 10.1182/bloodadvances.2021006862.
10
Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US.接种 Ad26.COV2.S 后发生致命性疫苗诱导的免疫性血栓性血小板减少症（VITT）：首例美国以外的确诊病例。
Infection. 2022 Apr;50(2):531-536. doi: 10.1007/s15010-021-01712-8. Epub 2021 Oct 9.

引用本文的文献

1
[Antiplatelet factor 4 (PF4)-associated disorders: from drug adverse reactions to thrombotic disease].[抗血小板因子4（PF4）相关疾病：从药物不良反应到血栓形成性疾病]
Inn Med (Heidelb). 2025 Jul 25. doi: 10.1007/s00108-025-01935-z.
2
Adenovirus vectors can infect mouse megakaryocytes - implications for vaccine-induced thrombosis/thrombocytopenia.腺病毒载体可感染小鼠巨核细胞——对疫苗诱导的血栓形成/血小板减少症的影响。
Res Pract Thromb Haemost. 2025 Jun 2;9(4):102909. doi: 10.1016/j.rpth.2025.102909. eCollection 2025 May.
3
VITT Pathophysiology: An Update.
疫苗诱导的血栓性血小板减少症（VITT）的病理生理学：最新进展
Vaccines (Basel). 2025 Jun 17;13(6):650. doi: 10.3390/vaccines13060650.
4
Anti-PF4 mediated thrombocytopenia and thrombosis associated with acute cytomegalovirus infection displays both HIT-like and VITT-like characteristics.抗PF4介导的血小板减少症和与急性巨细胞病毒感染相关的血栓形成表现出类似肝素诱导的血小板减少症（HIT）和疫苗诱导的免疫性血小板减少症（VITT）的特征。
Br J Haematol. 2025 Jun;206(6):1737-1742. doi: 10.1111/bjh.20092. Epub 2025 Apr 29.
5
Anti-Platelet factor 4 immunothrombosis-not just heparin and vaccine triggers.抗血小板因子4免疫性血栓形成——不仅仅是肝素和疫苗引发的。
Res Pract Thromb Haemost. 2025 Mar 12;9(2):102729. doi: 10.1016/j.rpth.2025.102729. eCollection 2025 Feb.
6
Destabilization of PF4-antigenic complexes in heparin-induced thrombocytopenia.肝素诱导的血小板减少症中PF4抗原复合物的不稳定
Blood. 2025 Jun 19;145(25):3030-3040. doi: 10.1182/blood.2024025653.
7
Endothelial cell activation enhances thromboinflammation in vaccine-induced immune thrombotic thrombocytopenia.内皮细胞活化增强疫苗诱导的免疫性血栓性血小板减少症中的血栓炎症反应。
Blood Adv. 2025 Jun 24;9(12):2891-2906. doi: 10.1182/bloodadvances.2024014165.
8
Beyond platelet activation: dysregulated lipid metabolism in defining risk and pathophysiology of VITT.血小板活化之外：VITT风险及病理生理学定义中的脂质代谢失调
Res Pract Thromb Haemost. 2025 Jan 9;9(1):102677. doi: 10.1016/j.rpth.2025.102677. eCollection 2025 Jan.
9
Recombinant Anti-PF4 Antibodies Derived from Patients with Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Facilitate Research and Laboratory Diagnosis of VITT.源自疫苗诱导的免疫性血小板减少症和血栓形成（VITT）患者的重组抗PF4抗体有助于VITT的研究和实验室诊断。
Vaccines (Basel). 2024 Dec 24;13(1):3. doi: 10.3390/vaccines13010003.
10
Mini-clusters of postadenovirus VITT.腺病毒后疫苗诱导的血小板减少症的微型聚集物
Res Pract Thromb Haemost. 2024 Nov 26;9(1):102641. doi: 10.1016/j.rpth.2024.102641. eCollection 2025 Jan.